Limited coverage criteria – vortioxetine

Last updated on March 24, 2025

 

Return to Special Authority drug list 

Generic name

vortioxetine hydrobromide

Strength & form

5 mg, 10 mg, and 20 mg oral tablets

Special Authority criteria

Approval period

Major depressive disorder (MDD) in adult patients

AND

Treatment failure or intolerance to at least 2 other specified antidepressants for MDD treatment

Indefinite

Practitioner exemptions

  • None

Special notes

  • Criteria applicable to all plans, including Plan G

Special Authority request form(s)